The company is using a recently closed funding round to drive commercialization of the test, which measures three proteins in urine to detect pancreatic cancer.

Siemens Healthineers will leverage its regional network and healthcare technology expertise to support the adoption of Aiforia's pathology tools.

The blood-based test detects phosphorylated tau 181, a biomarker that is correlated with the presence of amyloid pathology in ...

The firm hopes to exploit its first-mover advantage in the OTC space following de novo clearance for an at-home PCR test to detect sexually transmitted infections.

The company plans to conduct a three-year study of Parkinson's risk among people with essential tremor, using its Syn-One Test.

The new swab technology allows for non-invasive collection of patient samples without the need for liquids or complex devices.

The company noted that if PAMA cuts go into effect at the beginning of next year as scheduled, they would negatively impact its 2026 revenues by around $100 million.

NEW YORK – The US Food and Drug Administration in August granted 510(k) marketing clearances for various antimicrobial susceptibility tests, several respiratory disease tests, and a cardiac troponin ...

NEW YORK – In acquiring CRISPR intellectual property from Mammoth Biosciences, VedaBio aims to further reduce the turnaround time and cost of its diagnostic test system. VedaBio CEO Frederic Sweeney ...

NEW YORK — Quest Diagnostics has revamped its pharmacogenomics offerings (PGx) to provide a more narrowly tailored panel of genes with the goal of offering physicians clearer, more actionable ...

NEW YORK – Canadian diagnostic firm MedMira has developed a portable reader and test cartridges for blood-based point-of-care testing that uses its proprietary lateral flow technology. If all goes ...